Loading clinical trials...
Loading clinical trials...
Flurbiprofen Axetil as an Adjuvant to Pre-emptive Scalp Infiltration for Post-craniotomy Pain
Conditions
Interventions
FA plus ropivacaine
ropivacaine alone
Locations
1
China
Beijing Tiantan Hospital
Beijing, China
Start Date
November 1, 2023
Primary Completion Date
March 1, 2026
Completion Date
March 1, 2026
Last Updated
October 6, 2025
NCT06862609
NCT07327463
NCT07436806
NCT07442721
NCT07440940
NCT07413055
Lead Sponsor
Beijing Tiantan Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions